Summary
This article discusses how hormone replacement therapy (HRT) can relieve menopause and low testosterone symptoms while supporting bone, heart, and overall health, but the decision of whether and when to start or stop should be made individually with a healthcare provider.
Introduction
Hormone replacement therapy (HRT) is one of the most effective treatments for restoring balance when natural hormone levels decline. In women, hormone production begins to fluctuate in the mid-thirties, with symptoms like hot flashes, poor sleep, mood changes, and bone changes often appearing in the forties. Men experience a gradual decline in testosterone with age, which can cause fatigue, decrease in muscle mass, and mood changes.
Deciding when to start or stop HRT is not a one-size-fits-all process. Clinical research shows that timing, health history, and personal goals all play an important role in making this decision.
When to Start HRT
For women, HRT is often considered during perimenopause, when symptoms begin to interfere with daily life. Studies consistently show that starting hormone therapy closer to menopause, ideally within 10 years of onset or before age 60, provides the most favorable balance of benefits to risk. Research has demonstrated benefits in bone strength, cardiovascular health, and reductions in all-cause mortality when treatment is started closer to menopause [1-3].
Some women may benefit from starting sooner. Those with early or surgical menopause are often encouraged to begin therapy to protect long-term health. Women with conditions like polycystic ovary syndrome (PCOS) may also
consider earlier intervention depending on their individual health needs and goals.
For men, testosterone replacement therapy (TRT) may be considered when symptoms such as fatigue, mood changes, or reduced libido occur in combination with confirmed low testosterone levels.
Adjusting and Optimizing Treatment
Beginning HRT is not an instant fix. It may take several months to find the right dose and delivery method. Small adjustments are often needed, and close communication with a provider during this time is important. Patience is key, since hormones influence multiple systems in the body, and every individual’s balance looks different. Regular reassessment to ensure appropriateness of therapy is essential as health needs and life circumstances change over time.
When to Stop HRT
There is no set rule for when to stop hormone therapy. Some patients may choose to stop because of changes in health, personal goals, or side effects, while others continue for many years if the benefits outweigh the risks. Current evidence shows that ongoing therapy may provide benefits beyond symptom relief, including preservation of bone and cardiovascular health [4]. If stopping hormone therapy becomes appropriate, tapering gradually is safer and more comfortable than an abrupt stop, and the decision should always be made with a healthcare provider.
Conclusion
Every patient’s hormone journey is different. There is no universal timeline for when to start or stop HRT. The best approach is an individualized plan, developed with a knowledgeable provider, that considers symptoms, goals, and evolving health needs.
Carie Boyd Pharmaceuticals provides multiple HRT options, including estrogen, progesterone, testosterone, and DHEA in a variety of forms and dosages. Working closely with providers, we support safe, effective, and personalized care to help patients maintain quality of life at every stage.
Coming Soon...
Stay tuned for our next article discussing clomiphene!
- Flores, V. A., Pal, L., & Manson, J. E. (2021). Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocrine reviews, 42(6), 720–752. https://doi.org/
- Langer, R. D., Hodis, H. N., Lobo, R. A., & Allison, M. A. (2021). Hormone replacement therapy – where are we now?. Climacteric : the journal of the International Menopause Society, 24(1), 3–10. https://doi.org/
- “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (New York, N.Y.), 29(7), 767–794. https://doi.org/
- Genazzani, A. R., Monteleone, P., Giannini, A., & Simoncini, T. (2021). Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human reproduction update, 27(6), 1115–1150. https://doi.org/